Improved prediction of long-term kidney outcomes in people with type 2 diabetes by levels of circulating haematopoietic stem/progenitor cells.
Benedetta Maria BonoraMario Luca MorieriMarella MarassiRoberta CappellariAngelo AvogaroGian Poalo FadiniPublished in: Diabetologia (2023)
HSPC levels predict worsening of kidney function and improve the identification of individuals with type 2 diabetes and adverse kidney outcomes over and beyond a clinical risk score.